- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- The 10 Poorest States in America
Blindly following other people into trades can lead to painful losses.
Cybersecurity is a hot industry right now, and a new player might be a good investment ahead of earnings next week.
A lesson in 'sympathy' trading. That is, buying a stock that is similar to one that is moving strongly.
With no clear direction in the market, picking individual stocks has been key to making money in 2015.
With many parts of the world battling drought, this penny stock might be one to take a closer look at.
It Is As Simple As High School Economics
With the FDA backing its first 'biosimilar' drug, it may be time to invest in this new area of growth for pharmaceuticals.
Here's how investors can help fund the next cure for cancer: anti-CD47 antibody therapies.
Move over 3D Systems and Stratasys. A 46-year-old Hurco has filed a U.S. patent for what may be disruptive technology that combines 3D printing with your basic CNC machine.
Everywhere, there's talk of gluten-free diets. Here's an undervalued growth stock to get exposure to the trend.